Kaleo

Kaleo, Inc. is a pharmaceutical company based in Richmond, Virginia, founded in 2008. It specializes in developing, marketing, and selling combination drug/device products aimed at empowering patients to manage their medical conditions more effectively. Notable products include AUVI-Q, an epinephrine auto-injector designed for infants and small children experiencing severe allergic reactions, and EVZIO, a naloxone HCl injection for opioid overdoses. The company emphasizes drug delivery technology, human factors engineering, and a patient-centric approach to product development, ensuring that its offerings provide clinical and economic benefits. Kaleo distributes its products primarily through distributors in the United States and Canada and was formerly known as Intelliject, Inc., a name it adopted in January 2014.